-
公开(公告)号:EP4061399A1
公开(公告)日:2022-09-28
申请号:EP20808127.3
申请日:2020-11-20
申请人: Arla Foods amba
-
公开(公告)号:EP4349402A2
公开(公告)日:2024-04-10
申请号:EP24156819.5
申请日:2020-11-20
申请人: Arla Foods amba
发明人: MOSE, Maike , RITTIG, Nikolaj Fibiger , MØLLER, Niels , MIKKELSEN, Ulla Ramer , FREDERIKSEN, Pernille Dorthea , LAURIDSEN, Kasper Bøgelund , CHRISTENSEN, Britt , MARKHOLM, Mie , NIELSEN, Søren Bang , JÆGER, Tanja Christine , SMEDEGAARD, Stine Bech , HULMAN, Adam
IPC分类号: A61P3/10
摘要: The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atrophy in a subject. It furthermore pertains to use of a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for increasing the level of insulin and/or glucagon in the blood of a subject and the present invention also pertains to a non-therapeutic use or method of a) beta-lactoglobulin or b) a nutritional composition comprising BLG. It also pertains to beta-lactoglobulin (BLG) for use in preventing and/or treating diabetes or prediabetes in a subject. It furthermore pertains to a nutritional composition for use in preventing and/or treating diabetes or prediabetes in a subject.
-
公开(公告)号:EP4349402A3
公开(公告)日:2024-06-19
申请号:EP24156819.5
申请日:2020-11-20
申请人: Arla Foods amba
发明人: MOSE, Maike , RITTIG, Nikolaj Fibiger , MØLLER, Niels , MIKKELSEN, Ulla Ramer , FREDERIKSEN, Pernille Dorthea , LAURIDSEN, Kasper Bøgelund , CHRISTENSEN, Britt , MARKHOLM, Mie , NIELSEN, Søren Bang , JÆGER, Tanja Christine , SMEDEGAARD, Stine Bech , HULMAN, Adam
CPC分类号: A61K38/1722 , A61P3/10 , A23L33/19
摘要: The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atrophy in a subject. It furthermore pertains to use of a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for increasing the level of insulin and/or glucagon in the blood of a subject and the present invention also pertains to a non-therapeutic use or method of a) beta-lactoglobulin or b) a nutritional composition comprising BLG. It also pertains to beta-lactoglobulin (BLG) for use in preventing and/or treating diabetes or prediabetes in a subject. It furthermore pertains to a nutritional composition for use in preventing and/or treating diabetes or prediabetes in a subject.
-
-